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Although great strides have been made in the areas of ventricular pacing, it is still
appreciated that dyssynchrony can be malignant, and that appropriately placed pacing
leads may ameliorate mechanical dyssynchrony. However, the unknowns at present
include:
1. The mechanisms by which ventricular pacing itself can induce dyssynchrony;
2. Whether or not various pacing locations can decrease the deleterious effects caused
by ventricular pacing;
3. The impact of novel methods of pacing, such as atrioventricular septal, lead-less, and
far-field surface stimulation;
4. The utility of ECG and echocardiography in predicting response to therapy and/or
development of dyssynchrony in the setting of cardiac resynchronization therapy
(CRT) lead placement;
5. The impact of ventricular pacing-induced dyssynchrony on valvular function, and
how lead position correlates to potential improvement.
This review examines the existing literature to put these issues into context, to provide
a basis for understanding how electrical, mechanical, and functional aspects of the heart
can be distorted with ventricular pacing. We highlight the central role of the mitral valve
and its function as it relates to pacing strategies, especially in the setting of CRT. We also
provide future directions for improved pacing modalities via alternative pacing sites and
speculate over mechanisms on how lead position may affect the critical function of the
mitral valve and thus overall efficacy of CRT.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V.
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Cardiac pacing is an established and effective treatment for
sinus node disease and atrioventricular block [1,2]. The right
ventricular (RV) apex has been the standard pacing site since
the development of implantable pacemaker technology
because of the relative ease of access, lead stability, and the
presumed safety of the right-sided circulation compared to
the left (fewer fatal thromboembolic sequelae) [3]. However,
several studies have shown that RV apical pacing creates
electrical dyssynchrony and has detrimental effects on car-
diac structure, function, and can lead to development of atrial
fibrillation, valvular regurgitation and severe congestive heart
failure [4e12].
Cardiac resynchronization device therapy (CRT) has shown
to improve morbidity and mortality in patients with conges-
tive heart failure [13e16], and recent trial data has expanded
the indications for its use [17e24]. CRT is thought to improve
atrioventricular, intraventricular and interventricular dys-
synchrony through the simultaneous activation of the RV and
the left ventricle (LV) [1]. The Achilles heel of CRT is the sub-
stantial number (up to 1/3) of patients that do not benefit,
termed “non-responders” [25].
The utility of baseline electrocardiogram (ECG) in detecting
dyssynchrony, together with multiple imaging and device
based studies have attempted to identify criteria for improved
patient selection, but no single validated and reliable marker
has been identified [26e28]. Alternative pacing locations and
the impact of novel pacing methods such as atrioventricular,
leadless and far-field stimulation from the surface of the heart
seem to decrease the deleterious dyssynchronous effects of
pacing [29e31].
Finally, pacing-induced dyssynchrony affects valvular
function as well. Tricuspid and mitral regurgitation occur or
worsen if abnormal ventricular mechanic is present [32e34],
and appropriately placed pacing leads can actually improve
valvular function through various mechanisms [35e37].
We review the current knowledge on RV pacing and CRT,
provide an overview on pacingmodalities andmechanisms of
dyssynchrony-induced ventricular dysfunction and valvular
regurgitation, ways to improve CRT through innovation, and
how this can be translated to tangible therapeutic options that
are safe, effective, and mechanistically sound.Ventricular pacing effects on the electrical,
mechanical, and structural functions of the heart
Part 1. Electrical activation of the heart, pathophysiology of
pacing and why mechanical dysfunction occurs from
ventricular pacing
During normal sinus rhythm, electrical activation occurs
through the cardiac conduction system. The depolarization
wave front spreads sequentially from the atria, to the atrio-
ventricular node, through the His-Purkinje system, resulting
in almost simultaneous activation of both ventricles. The
result of this is manifesting on ECG as a narrow QRS com-
plex. In contrast, RV apical pacing causes the earliest depo-
larization to occur at the segment of the RV apex, followed by
slow, cell-to-cell spread of the activation wavefront, with
latest depolarization at the inferoposterior base of the LV
[38]. This produces a wide QRS and a left superior axis on
ECG.
RV pacing produces an iatrogenic form of left bundle
branch block (LBBB). Native LBBB can cause hemodynamic
deterioration due to ventricular dyssynchrony, mainly in pa-
tients with heart failure. However, LBBB induced by RV apical
pacing seems to lead to worse outcomes when compared to
native LBBB, increasing ventricular dyssynchrony [39e41].
The latest LV mechanical activation during RV apical pacing,
indeed, is different from that during native LBBB, being more
delayed at the baso-lateral LV wall [42].
The abnormal electrical and mechanical activation
caused by RV apical pacing reduces stroke volume and cau-
ses a right-shift of the left ventricular end-systolic pressur-
eevolume relationship. In addition to hemodynamic
consequences, RV apical pacing can worsen coronary blood
flow, regional myocardial fiber shortening, and any pre-
existing mechanical dyssynchrony [12,43,44]. Moreover,
regional patterns of ventricular activation are also altered in
a complex manner [45]. Early activation of the RV apex re-
sults in vigorous RV apical shortening. Early apical short-
ening leads to stretching of remote ventricular regions, such
as the LV free wall, and subsequent stronger contraction of
these regions is needed compared to the local RV apical re-
gions. Another important mechanical effect of RV apical
pacing is abrupt posterior motion of the interventricular
Fig. 2 e Illustration showing RV lead located at the RV apex
and LV lead inside the coronary sinus. On right-sided
panel, differences in QRS duration in lead I and V1 during
RV pacing alone, LV pacing alone, and simultaneous
biventricular pacing.
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pressure in the RV compared to the LV and results in a
decrease in left ventricular end diastolic volume, and
consequently reduction in the cardiac output.
Several studies have shown superiority of CRT compared
to standard RV apical pacing in terms of survival and
freedom from heart failure both in patients with preserved
and reduced ejection fraction [15e23]. Typically, in CRT de-
vices three pacing leads are placed: one in the right atrium,
a second one on the endocardial aspect of the RV apex, and
a third lead is placed transvenously through the coronary
sinus to pace the epicardial wall of the LV. During CRT
pacing, the electrical activation of the myocardium occurs
again through a cell-to-cell mechanism, but the simulta-
neous pacing from the RV and the LV leads to a decrease in
the electrical delay, increases coordinated contraction be-
tween the different walls of the heart, and results in a
narrower QRS complex on the surface ECG (Figs. 1 and 2).
Simultaneously stimulation of the RV and LV, therefore,
should restore a coordinated pumping action. Electrical
resynchronization between the RV and LV should eliminate
both the LBBB-induced mechanical dyssynchrony due to a
preexisting cardiomyopathy and the LBBB-induced dyssyn-
chrony caused by RV apical pacing alone [47]. However, as
previously stated, RV apical pacing increases ventricular
dyssynchrony compared with intrinsic LBBB. For this
reason, if LV pacing alone is performed with such an atrio-
ventricular delay able to ensure intrinsic activation of the
heart via the right bundle branch (RBB), the fusion of these
two depolarization wave fronts should be more effective
than biventricular pacing [48e50]. Varma et al. [49] used
electrocardiographic imaging to compare RV activation
during intrinsic conduction and during pacing in patients
with heart failure. Patients with normal RBB-mediated de-
polarization showed normal RV free wall activation,
whereas they developed activation delay when RV pacing
was switched on, alone or in a biventricular fashion. These
data again suggest that merging of LV paced and intrinsic
RBB wave fronts could be beneficial. Moreover, program-
mability of the inter-ventricular interval between RV and LV
stimulation may further improve hemodynamics [51].Fig. 1 e Illustration showing spread of electrical activation of th
pacing (simultaneous RV apical and LV lateral wall pacing).Part 2. Electrical manifestations that correlate with
dyssynchrony
Baseline QRS duration is one of the most commonly used
parameters in patient selection for CRT, but remains a weak
criterion to predict response [52e54]. Current guidelines [1,2]
suggest CRT implant in patients with heart failure and QRS
duration >150 ms, or with an additional indicator of supposed
good response, such as LBBB morphology, if the QRS is
120e150 ms. Right bundle branch block or aspecific intraven-
tricular conduction delay seem to predict no positive effect or
even be responsible for negative response to CRT [27]. How-
ever, several studies have shown that neither QRS duration at
implant nor shortening of QRS after implant necessarily pre-
dicts clinical benefit from CRT [28,55e57]. Recently, a study
from Del-Carpio Munoz et al. [58] showed that a noninvasive
method of determining LV activation delay, by analyzing the
time to intrinsicoid deflection onset on surface ECG, repre-
sents a promising alternative to QRS duration to predict CRTe myocardium during RV apical pacing versus biventricular
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a survival benefit of CRT devices in patients with LBBB
compared to the group of patients assigned to defibrillators
alone, independently to QRS duration [59]. On the other hand,
a recent trial showed that in patients with heart failure and
with QRS duration < 130 ms, CRT didn't reduce the rate of
death or hospitalization and might even increase mortality,
even if mechanical dyssynchrony was present [60].
Electrical dyssynchrony and mechanical dyssynchrony
could be two different entities, as explained by the concept of
“electromechanical dissociation.” [52] Electromechanical
coupling interval can significantly be different on a patient-
to-patient basis, and not strictly related to the widening of
the QRS complex. Electromechanical delay, defined as the
time between the regional electrical depolarization and the
onset of myocardial fiber contraction, or mechanical activa-
tion, is responsible for additional electromechanical dys-
synchrony. The mechanical delay between early and late-
activated myocardial segments exceeds the delay in elec-
trical activation during LBBB and during pacing-induced
dyssynchrony [61,62], aggravating mechanical relative to
electrical dyssynchrony.
Moreover, latency from pacing stimulus to the onset of the
earliest QRS further impacts on optimal delivery of CRT [63].
Latency has shown to be more prevalent during LV pacing
from the epicardial veins than during RV endocardial pacing,
possibly due to the longer distance from the subendocardial
His-Purkinje system, interposed epicardial fat, venous tissue
and slow impulse propagation in scarring and diseased
myocardium [64].
It has been thought that ischemic patients have been less
responsive to CRT, propagating studies to assess for amount
and location of scar to CRT response [65,66]. The amount of
scar and its location in the posterolateral segment of the LV
appear to be a predictor of CRT non-response [67]. Delayed-
enhancement magnetic resonance imaging is a useful tool
to predict clinical response to CRT [68e70]. Even if studies
showed that scar does not preclude myocardial capture,
pacing regions of the myocardium characterized by scar
tissue may not be translated into effective mechanical
contraction, because both absence of sufficient viable tissue
to be recruited with CRT and also because of inadequate
synchronization due to scar presence [71]. Moreover, the
higher percentage of CRT “non-responders” among patients
with ischemic heart disease seems to be ascribed more likely
to conduction abnormalities and electrical substrate issues
rather than cardiomyopathy etiology itself.
Non-response to CRT appears to be associated to a myriad
of electro-mechanical events. Dendy et al. [72] found anodal
stimulation as an additional cause of poor response to CRT.
Anodal stimulation is defined as capture at the pacing anode
instead of cathode and is sometimes unrecognized perioper-
atively [73]. In patientswith CRT, pacing from the LV tip or ring
to the coil or ring of the RV lead is often used due to lower
pacing thresholds. Pacing configuration of LV to RV can lead to
clinically significant anodal stimulation resulting in RV cap-
ture during attempted LV pacing. If the benefit from CRT oc-
curs through improvement in LV late depolarization, CRTwith
anodal stimulation essentially results in RV pacing alone,
leading to persistent interventricular and intraventricularconduction delay to the LV lateral wall. However, Lloyd et al.,
using left ventricular outflow tract velocity time integral as a
marker of response, showed anodal pacing to markedly
improve this parameter compared to cathodal pacing in 36/37
recordings [74]. Additionally, controversy exists over whether
anodal pacing is beneficial or harmful. This is partially driven
by the complexities in defining what an adequate response to
CRT is. For example, it can be symptomatic improvement, or a
marker of mechanical improvement depending on the fact
that an invasive catheter based assessment such as dP/dt or
an echocardiographic based assessment such as ejection
fraction, dP/dt, Doppler is used. Both animal and clinical
studies have demonstrated improved mechanical perfor-
mance by anodal stimulation, and this is thought to be due to
activation of larger volume ofmyocardium, increased amount
of sodium available, and more rapid conduction velocity
[75,76].
Part 3. Valvular Regurgitation
The first known association of tricuspid regurgitation (TR) and
device implantation was described in 1980 [77]. Since then,
several case reports and observational studies have supported
this association. Both new onset TR and worsening TR can
occur by the mechanical effects of lead implantation or elec-
trical dyssynchrony, which can occur early or late after device
implantation [78e81]. Conversely, some small studies have
suggested an improvement of TR after pacing [82]. The prev-
alence of TR is 25%e50% in patients with pacemaker vs no
pacemaker [83,84]. The clinical presentation of TR is highly
variable, from asymptomatic and incidentally detected on
echocardiography, to the more severe clinical presentation of
right-sided heart failure. The mechanism of TR after device
implantation includes valve tethering, inadequate leaflet
coaptation due to the physical presence of lead, lead adher-
ence due to fibrosis and scar formation, lead entrapment in
the subvalvular apparatus, valve perforation, valve laceration,
and annular dilatation [77,85,86].
Long-term RV apical pacing is also responsible for causing
mitral regurgitation (MR) due to LV dyssynchrony. A study
from Alizadeh et al. shows how degree of MR can worsen
during follow-up in patients with permanent apical RV pacing
[32]. There are a few reported cases of acute severe MR as an
immediate perioperative complication of pacemaker inser-
tion, leading to acute hemodynamic deterioration, even in
patients with preserved LV ejection fraction [87e91]. The
mechanism of this includes mitral annular dilatation and
abnormal leaflet coaptation perhaps due to the abnormal LV
activation sequence [92,93]. It is likely that the inversion of the
ventricular activation sequence with RV apical pacing is
associated with a delayed reduction of both mitral annulus
size and regurgitation orifice size, and this enhances MR
severity [35]. Furthermore, if alteration in timing of papillary
muscle contraction is corrected with a different lead location
in the RV (such as the right ventricular outflow tract) or with a
left-sided pacing system, degree of MR has been shown to
improve [94].
Moreover, the presence ofMR in patientswith heart failure,
before device implantation, has been showed to be an inde-
pendent predictor of worsened survival [95,96]. This type of
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dilatation of the left ventricle. Three main mechanisms are
involved in secondary MR: 1) mitral annular dilatation, 2)
decreased LV global systolic function, responsible for slow rise
of intraventricular pressure and slow closure ofmitral leaflets,
3) increased LV sphericity with subsequent displacement and
malposition of the papillary muscles, leading to decreased
longitudinal systolic function and increased mitral valve
tethering forces (Fig. 3) [33,34]. Recently, Topilsky et al. [97]
used 3D transthoracic echocardiography to show the com-
plex interaction between mitral valve dynamics and ventric-
ular contraction. The loss of annular contraction across the
inter-commissural axis, usually responsible for early-systolic
mitral competence, and the change in papillary muscle dy-
namics were linked to the severity of MR. Moreover, the
presence of LBBB itself in patients with dilated cardiomyopa-
thy, increasing LV isovolumic contraction and relaxation
times, is responsible for worsening MR duration [98].
Cardiac resynchronization therapy, reducing electrical and
mechanical dyssynchrony and leading to a final increased
efficiency of LV contraction, has shown to have beneficial ef-
fects on ‘secondary’ MR [35e37,94,99e101]. Kanzaki et al. [36],
utilized echocardiographic Doppler and strain images before
and immediately after CRT implant, and showed a significant
reduction in the coordinated timing of mechanical activation
of papillary muscle insertion sites and in the severity of MR
after CRT implant (p < 0.001 for both comparisons). Agricola
et al. [34], showed how CRT may reduce the delay in electrical
activation and subsequentmechanical activity of the papillary
muscle, improving contraction coordination. They stated that,
with enlarged spheric ventricle, both papillary muscles are
posteriorly displaced. The anterolateral papillary muscle
shifts far from interventricular septum and more towards the
posterior/posterolateral veins, where the left-sided CRT lead
is usually implanted. In this way, the stimulation of the LV
free wall can counterbalance the delay in electrical activation
of the anterior papillary muscle caused by LBBB and improve
muscle coordination. Matsumoto et al., [102] instead, showed
an asymmetrical displacement of papillary muscles in pa-
tients with dilated cardiomyopathy, with the anterolateral
papillary muscle being more posteriorly located than the
posteromedial one. The restoration of the anterolateral
papillary muscle position after CRT implant was one of the
independent predictors of MR reduction at 6 month followup.
Moreover, thanks to a more coordinated and earlier me-
chanical contraction of the basal segments of the LV
compared to the more apical ones, an increase in mitral
annular systolic function may be achieved, leading to reduc-
tion of MR [94,99]. Earlier mitral annular contraction was hy-
pothesized to be the responsible mechanism of a dramatic
symptom improvement in a patient with RV pacing and heart
failure who subsequently underwent an upgrading to a
biventricular device with the LV lead being positioned in a
very basal-lateral position. DeSimone et al., [103] indeed,
observed an acute and significant reduction in MR and LV size
dimensions with proper LV lead placement causing mitral
annular pre-excitation. Ypenburg et al. [35] reported findings
consistent with this by showing an acute improvement in MR
after CRT, as well as during follow-up. In addition to the 43%
acute improvement, the authors demonstrated a 20%reduction of late MR 6 months after CRT. Moreover, the
beneficial effects of CRT are maintained until the therapy it-
self is interrupted, possibly suggesting a dynamic influence on
mitral valve activation kinetics. Following CRT withdrawal,
acute loss of synchronization is responsible for acute MR
recurrence and worsening in mitral functional parameters
[94].Future directions
Understanding the mechanism of how mitral valve me-
chanics and other dyssynchrony parameters are improved
with biventricular pacing will provide critical data necessary
to improve number of CRT response in patients with heart
failure. The location where transvenous LV leads are placed
via the coronary sinus has been considered of utmost
importance for CRT optimal response [104]. Meanwhile,
stimulation sites alternative to RV apical pacing have been
extensively studied to simulate a more physiologic electrical
activation of the heart, to reduce ventricular dyssynchrony
and to obtain more favorable hemodynamics. Few studies
regarding non-traditional pacing sites in the right ventricle,
such as the RV septum or the RV outflow tract, and His-
bundle pacing have been reported in the literature (Fig. 4)
[84,105e111].
The RV outflow tract has been considered primarily
because placement of leads is technically easier compared to
most other locations. The reason for interest in this region is
that activation should result in electrical propagation from
base to apex with a QRS morphology more similar to the
standard QRS derived from normal cardiac conduction sys-
tem, even if the duration of the QRS itself may not be signifi-
cantly improved [112e115]. RV mid-septal pacing has also
been used as an alternative to RV apical pacing [116]. Even if
lead implantation in the inter-ventricular septum has showed
to be feasible, safe, and associated with less ventricular dys-
synchrony compared to standard apical pacing, no overt
clinical benefits have been found [117e119]. However, both of
these alternative sites still require crossing the tricuspid valve,
with the potential risk of TR.
His-bundle pacing was first demonstrated in 1967 in dogs
[120]. However, in this location, stable capture is difficult to
obtain and higher thresholds and longer implant times are
often necessary [121,122]. The issues with His-bundle pacing
may be partially attenuated with parahisian pacing, in which
both the His and the myocardium of the high interventricular
septum are stimulated together [123]. However, parahisian
pacing produces a base-to-apex activation pattern that is
completely different from the true His-bundle capture, char-
acterized by the earliest site of ventricular activation at the
exit site of the right and left bundle.
More novel approaches include lead-less pacemakers such
as the ‘Nanostim’ (St. Jude Medical Inc., Minneapolis, MN,
USA) [124] and the ‘Micra™ Transcatheter Pacing System’
(Medtronic Inc., Minneapolis, MN, USA) which was recently
implanted inman (NCT02004873,www.clinicaltrials.gov). Other
lead-less pacing systems use ultrasound-based technology
and have been tested clinically for short-termuse in LV pacing
[31]. A comparison of lead-less RV apical pacing with
Fig. 3 e Panel A: Mechanisms of mitral regurgitation in patients with heart failure. Panel B: Beneficial effects of CRT on
‘secondary’ mitral regurgitation.
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mechanisms of both MR and TR: how much is mechanically
caused by the leads vs. electrical dyssynchrony from the RV
apical pacing.
Concerning the use of CRT devices, with advances in cor-
onary sinus cannulation and dedicated LV technology, thetransvenous approach through the coronary sinus itself has
become the standard technique, even if limitations such as
technical challenges in finding electrically suitable sites still
exist. Multisite pacing, mimicking the native conduction sys-
tem activation [125], or multipoint pacing [126], usingmultiple
electrodes on one LV lead, could optimize synchronous
Fig. 4 e Illustration showing alternative sites for RV pacing indicated by stars. LAF ¼ Left Anterior Fascicle; LBB ¼ Left
Bundle Branch; LPF ¼ Left Posterior Fascicle; RBB ¼ Right Bundle Branch; RVOT ¼ Right Ventricular Outflow Tract.
Fig. 5 e Gross anatomy and histological images showing the atrio-ventricular septum region. The tricuspid valve is more
apical than the mitral valve and the atrio-ventricular septum separates, at a certain location, the right atrium and the LV
basal septum. AVS ¼ Atrio-ventricular Septum; MV ¼ Mitral Valve; TV ¼ Tricuspid Valve.
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allow synchronous ventricular contraction without the need
to enter the coronary sinus or cross the tricuspid valve. Based
on the anatomical consideration that the tricuspid valve is
more apical than the mitral valve and the atrioventricular
septum separates, at a certain location, the right atrium and
the LV basal septum (Fig. 5), our group recently developed a
specially built intra-myocardial lead to pace the ventricular
myocardium from the atrioventricular septum itself [29,127].
The intra-myocardial lead, together with this new form of
synchronous pacing, could offer important advantages either
in patients without heart failure who require ventricular
pacing or in patients with heart failure who are candidates for
resynchronization therapy. Undoubtedly, larger studies withlong-term follow-up are needed to evaluate safety, stability
and durability of the novel lead and the enhanced potential
benefit of the atrioventricular septum location for pacing.Conclusions
The field of cardiac pacing is facedwith a great task to improve
the utility of ventricular pacing while mitigating potential for
undesired effects on heart structure and function. Further
research to clarify the relationship of the critical role that the
position and type of pacing leads have on proper mitral
valvular function is of paramount importance. Without
question, further innovative strategies will need to be
i n d i a n p a c i n g and e l e c t r o p h y s i o l o g y j o u rn a l 1 6 ( 2 0 1 6 ) 1 9e3 026employed and will be a work in progress as more pacing data,
especially with the increase in CRT use, become available in
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